Our recent study demonstrated a considerable impact of COVID-19 on adverse outcomes of patients with #pulmonaryembolism in 2020, which should guide attention to this special population. bit.ly/3zz3OjZ ERS European Society of Cardiology DIVI e.V. Universitätsmedizin Mainz

How come that noise exposure worsens outcomes post MI? Here‘s our new translational paper how environmental stress promotes vascular inflammation and deterioration of cardiac function @tmuenzel Omar Hahad DZHK Germany academic.oup.com/cardiovascres/…

Donnerstag, 11h, Saal 12! AG44 goes DGK FT23!

First implant worldwide of #Topaz transcatheter Tricuspid replacement in torrential TR in comb with pacemaker lead at Heart Valve Center in #Mainz and new in class 4D ICE to be shown at #EACTS in Vienna and #TCT in #SanFrancisco ⁦Univ.-Prof. Dr. Ralph Stephan von Bardeleben⁩ linkedin.com/posts/von-bard…

News in EHJ: Promises and challenges of targeting anti-CXCR3 autoantibodies in cardiovascular disease! academic.oup.com/eurheartj/adva… #cardioprotective #therapy #autoantibodies #G-protein #receptors #cardiotwitter European Society of Cardiology @ESC_journals

Worldwide first commercial #EVOQUE case today at #HeartvalveCenter #Mainz ⁦Universitätsmedizin Mainz⁩ closing the loop from interventional innovation to clinical reality a result of robust science a fantastic newly enhanced heart team. ⁦Philipp Lurz⁩ ⁦Univ.-Prof. Dr. Ralph Stephan von Bardeleben⁩

Happy to discuss results about catheter-directed treatment #cdt from our presented socio-economic model with leaders in the field of #pulmonaryembolism and the current president of the #PERTconsortium #aha2023 Rachel Rosovsky #timothymorris Stavros Konstantinides

The #ApolloEU #trial is now training and initiating trial centers in #Germany in December 2023. A new perspective for patients not suitable for heart surgery and #Mitralvalve TEER procedures. Initial US safety data very promising! More information [email protected]

🔥out now —> here’s our new paper from the MyBiopsy-HF study — enjoy !👉🏻Etiologies and predictors of mortality in an all-comer population of patients with non-ischemic heart failure | Clinical Research in Cardiology link.springer.com/article/10.100…

DanGer Shock! The first temporary mechanical support device shown to reduce mortality in patients with cardiogenic shock but there is an increased risk of complications. Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Shelley Zieroth Jason N. Katz Holger Thiele Abdulla A. Damluji, MD, PhD Alex Truesdell Michelle Graham